|
2002 Releases
|
| Date |
Title
(click to view the full text) |
| July 31, 2002 |
Antigenics’ Heat Shock Protein Technology Platform Expanded With 15 Key Patents |
| April 8, 2002 |
Antigenics’ Personalized Cancer Product Yields Promising Immunological Results in Melanoma and Colorectal Cancer Trials |
|
2001 Releases
|
| Date |
Title (click to view the full text) |
| December 18, 2001 |
Antigenics Adds Patent to Its Dominant Position in Heat Shock Protein Immunotherapy |
| October 15, 2001 |
Antigenics’ Oncophage(R) Becomes First Personalized Cancer Product To Receive FDA fast track Designation |
| July 25, 2001 |
Antigenics and Dr. Bruce Walker of Massachusetts General to Test Heat Shock Protein-Based Approach to HIV |
| May 14, 2001 |
Antigenics Presents Positive Data at ASCO |
| February 5, 2001 |
FDA Allows Antigenics to Start Clinical Trials In Patients With Genital Herpes |
| January 16, 2001 |
Antigenics Announces the Issuance of Six New Heat Shock Protein Patents |
|
2000 Releases
|
|
Date
|
Title
(click to view the full text) |
| November 27, 2000 |
Antigenics Expands Pancreatic Cancer Trial Based Upon Encouraging Results |
| November 14, 2000 |
Antigenics Wins Crucial Patent Battle With StressGen |
| October 17, 2000 |
Antigenics Expands Cancer Vaccine Clinical Program With Sarcoma Study |
| July 27, 2000 |
Nature Immunology Reports Antigenics’ Sequencing of Heat Shock Protein Receptor - A Critical Switch in Regulating the Immune System |
| June 28, 2000 |
Antigenics Launches First Phase III Trial Testing Its Cancer Vaccine |
| May 22, 2000 |
Results of Antigenics’ Cancer Vaccine in Two Clinical Trials Presented at ASCO |
| April 19, 2000 |
Antigenics Receives Patent Strengthening Its Position to Treat Infectious Diseases |
| April 5, 2000 |
Clinical Data on Antigenics’ Cancer Drug Presented at AACR |
| March 20, 2000 |
Antigenics Announces Start of Phase II Clinical Trial for Treatment of Non-Hodgkin's Lymphoma |
| March 9, 2000 |
Antigenics Expands Its Technology to the Field of Functional Genomics With The Issuance of Patents |
| January 4, 2000 |
Antigenics Announces Issuance Of Patent Covering Treatment Of Autoimmune Diseases With Heat Shock Proteins |
|
1999 Releases
|
|
Date
|
Title
(click to view the full text) |
| October 14, 1999 |
Antigenics Announces Issuance Of Patent Covering Heat Shock Protein-Based Vaccine Delivery Technology |
| May 18, 1999 |
Data On Antigenics Autologous Cancer Vaccine Presented At American Society Of Clinical Oncology Annual Meeting |
|
1998 Releases
|
|
Date
|
Title
(click to view the full text) |
| November 3, 1998 |
Antigenics Announces Issuance of Patent Covering Treatment of Cancer with Heat Shock Proteins in Combination with Adoptive Immunotherapy |
| October 13, 1998 |
Antigenics Establishes Autologous Cancer Vaccine Collaboration With Sigma-Tau |
| August 3, 1998 |
Antigenics Appoints Vice President of Process Development |
| May 12, 1998 |
Antigenics Receives Patent Covering The Use of Heat Shock Proteins for the Treatment of Cancer |
|
1997 Releases
|
|
Date
|
Title
(click to view the full text) |
| October 21, 1997 |
Vaccine Strategy for Cancer and Infectious Diseases |
| October 3, 1997 |
Immunotherapeutic Approach for Treating Metastatic Tumors Reported in Science |
